The Quantellect read.As of Nov 20, 2026, 25 active firms cover Amgen Inc: 9 rate it Buy or better, 14 sit at Neutral, and 2 rate it Sell or worse, a neutral consensus. Targets span $345.00 to $500.00, a moderate spread. The average target of $411.86 sits 6% below the current $439.12. The rating mix has stayed broadly stable, with Buy-side ratings easing from 10 to 9 over recent months. On the fundamentals, the Street sees revenue growth near 3% this year and 3% next, consensus EPS building from about $5.72 next quarter toward $25.08 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS25 active firms
Neutral
Strong Buy00%
Buy936%
Neutral1456%
Sell28%
Strong Sell00%
Based on 25 active firms as of Nov 20, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$411.86
-6.2% downside
Average target across 21 active firms as of Nov 20, 2026 vs $439.12 current
Highest Target$500.00
Average Target$411.86
Lowest Target$345.00
Detailed analyst forecasts for AMGN
Showing 1–21 of 21 named analysts shown · 25 active firms in the rating projection
As of Nov 20, 2026, 9 of 25 active firms rate AMGN a Buy (14 Neutral, 2 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
AMGN EPS & revenue forecast
EPS · NEXT QUARTER
$5.72
Range $5.13 – $6.09 · 9 analysts · +11% YoY
Next period, 9 analysts expect Amgen Inc to earn $5.72 a share (range $5.13 – $6.09), versus $5.15 a year earlier. Full-year consensus is $23.53, growing to $25.08 the year after.
REVENUE · NEXT QUARTER
$9.5B
Range $8.8B – $10.1B · 9 analysts · +1% YoY
Revenue is expected to reach $9.5B (range $8.8B – $10.1B), +1.0% year-over-year. Full-year consensus is $39.5B, rising to $41.3B next year.
Top analysts covering Amgen Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AMGN.
#1
Luca Issi
RBC Capital · Rank #76
Buy
$470.00+7.0% to target
Overall win rate
49%
+ Follow
#2
David Amsellem
Piper Sandler · Rank #124
Buy
$457.00+4.1% to target
Overall win rate
50%
+ Follow
#3
Vamil Divan
Guggenheim · Rank #211
Neutral
$435.00-0.9% to target
Overall win rate
48%
+ Follow
#4
Terence Flynn
Morgan Stanley · Rank #222
Neutral
$410.00-6.6% to target
Overall win rate
36%
+ Follow
#5
CS
Chris Schott
JP Morgan · Rank #287
Neutral
$425.00-3.2% to target
Overall win rate
41%
+ Follow
AMGN stock forecast FAQ
What is AMGN's average 12-month price target?+
The 21 active firms with a live target average $411.86 for Amgen Inc over the next 12 months, ranging from a $500.00 high to a $345.00 low, as of Nov 20, 2026.
Is AMGN stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 25 active firms as of Nov 20, 2026, 9 rate it Buy or Strong Buy, 14 rate it Neutral, and 2 rate it Sell or Strong Sell.
What are the highest and lowest price targets for AMGN?+
The Street-high target is $500.00 (Scotiabank), and the Street-low is $345.00 (Bernstein). The average of all 21 active-firm targets is $411.86.
How many active Wall Street firms cover AMGN?+
25 active firms have a recognized rating on Amgen Inc as of Nov 20, 2026, and 21 active firms carry a live 12-month price target.
Who is the most accurate analyst covering AMGN?+
Among analysts who currently cover AMGN, Luca Issi of RBC Capital has the strongest overall Quantellect track record (Rank #76). Their current call is Buy with a $470.00 target.
What is Amgen Inc's projected EPS for next quarter?+
The consensus estimate is $5.72 per share (range $5.13 – $6.09) across 9 analysts. Full-year EPS is projected at $23.53, rising to $25.08 the following year.
How much revenue is Amgen Inc expected to report next quarter?+
Consensus revenue is $9.5B (range $8.8B – $10.1B). Full-year revenue is projected at $39.5B, growing to $41.3B next year.
Have analysts been upgrading or downgrading AMGN lately?+
As of Nov 20, 2026, 9 of 25 active firms rate AMGN a Buy (14 Neutral, 2 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AMGN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.